The multidisciplinary breast conference

Read full text Summarise with VIRAT
Authors: Terry Sarantou, Dominique van Uden, Beth A. Overmoyer, Christobel Mary Saunders, Sabine Siesling, Pankaj G. Roy, Cary Steven Kaufman, Didier Verhoeven
Cited by: 0
References: 20

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Team-based care for a patient diagnosed with breast cancer is critical. The breast cancer disease-based team is composed of physicians from different specialties as well as nurses and other allied health staff. Breast cancer multidisciplinary breast conference (MBC), or tumour boards, allow experts to review a complex case and work together to develop and refine therapeutic strategy. In each case presented, the patient history with clinical, radiological, and pathological findings should be reviewed. Applicable treatment algorithms or care paths should be discussed routinely both before treatment and when full pathology is available to elevate the standard of care. Patients can be given access to clinical trials and important research. The multidisciplinary team (MDT) should meet at a given time (whether physically in one place or by video or teleconferencing) to discuss patients with breast cancer. The presence of an MDT, which meets at least fortnightly, is often a requirement or indicator for audits and accreditation. Breast cancer conferences should be accessible to all MDT members, participation should be tracked on scorecards, and MDT programmes should be accountable.

Fields of Study & Subjects

Interprofessional Education and Collaboration Breast Cancer Treatment Studies Breast Lesions and Carcinomas

Publication details

Journal / source
Oxford University Press eBooks
Pages
109–122
Publication date
1 March 2026
Language
EN
Document type
Book chapter